2020年8月巴西各首府城市症状出现与新冠病毒检测之间的时间间隔。
Time interval between onset of symptoms and COVID-19 testing in Brazilian state capitals, August 2020.
作者信息
Lima Francisca Elisângela Teixeira, Albuquerque Nila Larisse Silva de, Florencio Sabrina de Souza Gurgel, Fontenele Maria Gabriela Miranda, Queiroz Ana Paula Oliveira, Lima Glaubervania Alves, Figueiredo Lanese Medeiros de, Amorim Silvia Maria Costa, Barbosa Lorena Pinheiro
机构信息
Universidade Federal do Ceará, Departamento de Enfermagem, Fortaleza, CE, Brasil.
Secretaria de Estado da Saúde do Maranhão, Centro de Informações Estratégicas em Vigilância em Saúde, São Luís, MA, Brasil.
出版信息
Epidemiol Serv Saude. 2020 Dec 18;30(1):e2020788. doi: 10.1590/S1679-4974202100010002. eCollection 2020.
OBJECTIVE
To analyze notifications of flu-like syndrome according to the time interval between onset of symptoms and testing for COVID-19.
METHODS
This was a cross-sectional study using records of flu-like syndrome cases containing results of COVID-19 diagnostic tests in the Brazilian state capitals and Federal District, held on the e-SUS Notifica system, from March 1st, 2020 to August 18th, 2020. The time interval between symptom onset and testing was compared using the ANOVA test, classifying it according to test adequacy/timeliness.
RESULTS
Taking 1,942,514 notifications, average time between symptom onset and testing was 10.2 days (±17.1). Among those tested, females (55.1%), people aged 20-39 years (43.8%), and the Southeast region of Brazil (43.0%) predominated. 58.8% of IgM ELISA tests were performed at an adequate time while 68.0% of rapid antigen tests were not performed at an adequate time.
CONCLUSION
Inadequacy was found between symptom onset and time taken to test for COVID-19 in the Brazilian regions.
目的
根据症状出现与新冠病毒检测之间的时间间隔，分析流感样综合征通报情况。
方法
这是一项横断面研究，利用2020年3月1日至2020年8月18日在巴西各州首府和联邦区的电子卫生系统通报系统（e-SUS Notifica）上记录的流感样综合征病例记录，这些记录包含新冠病毒诊断检测结果。使用方差分析测试比较症状出现与检测之间的时间间隔，并根据检测的充分性/及时性进行分类。
结果
在1942514份通报中，症状出现与检测之间的平均时间为10.2天（±17.1）。在接受检测的人群中，女性（55.1%）、20至39岁人群（43.8%）以及巴西东南部地区（43.0%）占主导。58.8%的IgM酶联免疫吸附测定（ELISA）检测在适当时间进行，而68.0%的快速抗原检测未在适当时间进行。
结论
在巴西各地区，症状出现与新冠病毒检测所用时间之间存在不足。
Zotero 插件